Certara, Inc. (CERT) is in Healthcare, Health Information Services, based in United States, listed on NasdaqGS. Market cap 1.32B USD. 52-week range 4.45 to 13.11 USD. Trailing P/E 102.1. Data as of 2026-10-09.
Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based ...